Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.3200
+0.0010 (0.31%)
Oct 31, 2025, 5:38 PM GMT+1
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 6.26 million as of October 31, 2025. Its market cap has increased by 76.98% in one year.
Market Cap
6.26M
Enterprise Value
7.14M
Revenue
896.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.32
Market Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 6.26M, a decrease of -95.42%. That is a compound annual growth rate of -29.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 6.26M | 30.78% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | 76.82M | -29.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.37B |
| GSK plc | 71.55B |
| Haleon | 31.54B |
| Smith & Nephew | 11.91B |
| ConvaTec Group | 4.85B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.65B |